Cargando…
Evolution of frontline treatment of diffuse large B-cell lymphoma: a brief review and recent update
Various strategies have been implemented to improve the outcomes of diffuse large B-cell lymphoma (DLBCL). In recent years, remarkable advances have been achieved, based on the discovery of cell-of-origin in DLBCL and on more effective targeted agents. This commentary will summarize recent updates o...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979644/ https://www.ncbi.nlm.nih.gov/pubmed/27606052 http://dx.doi.org/10.12688/f1000research.8790.1 |